stars 1 stars 2 stars 3

Small molecules...global reach. We are experts in the design and production of small molecules for the pharmaceutical industry. We also apply our molecular expertise to the agriculture and veterinary industries and to our passion – water. We have been an innovator in the intermediates space for over three decades, developing proprietary techniques in the production of over 500 small molecules for the pharmaceutical industry. GIC’s intermediates are the precursors for many of today’s active pharmaceuticals. Our areas of expertise include ultra-pure nucleosides, B vitamin analogs, nucleosides, purine, pyridines, pyrimidines, oxidative halogenations, complex pyridine ring formations and bromoketones. GIC’s intermediates are commonly used by pharmaceutical companies in the production of anti-virals, MS drugs, asthmatics and oncology drugs. Some of our proprietary techniques enable single pot chemistry, eliminating costly purification steps, and the ability to perform reactions under atmospheric conditions, leading to higher purity and greater quality and consistency during production. GIC...better molecules by design.

General Intermediates Canada Questions

The General Intermediates Canada annual revenue was $200000 in 2026.

Glenn Weagle is the Chief Technical Officer of General Intermediates Canada.

3 people are employed at General Intermediates Canada.

General Intermediates Canada is based in Edmonton, Alberta.

The NAICS codes for General Intermediates Canada are [32, 32541, 325, 3254].

The SIC codes for General Intermediates Canada are [28, 283].

Top General Intermediates Canada Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users